Carl van Walraven

Publications

3 shown

Additive Role of Plasma von Willebrand Factor Levels to Clinical Factors for Risk Stratification of Patients With Atrial Fibrillation

Gregory Y.H. Lip , Deirdre A. Lane , Carl van Walraven +1 more

Background and Purpose— To aid decisions for thromboprophylaxis in atrial fibrillation (AF), several risk stratification schemes that predict stroke risk according to clinical a...

2006 Stroke 156 citations

Selecting Patients With Atrial Fibrillation for Anticoagulation

Brian F. Gage , Carl van Walraven , Lesly A. Pearce +4 more

Background— The rate of stroke in atrial fibrillation (AF) depends on the presence of comorbid conditions and the use of antithrombotic therapy. Although adjusted-dose warfarin ...

2004 Circulation 750 citations

Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation

Richard Hobbs , Peter J. Koudstaal , Palle Petersen +10 more

Background and Purpose— Stroke risk increases with age in patients who have nonvalvular atrial fibrillation. It is uncertain whether the efficacy of stroke prevention therapies ...

2009 Stroke 311 citations

Researcher Info

h-index: 3
Publications: 3
Citations: 1,217
Institution: The University of Texas Health Science Center at San Antonio

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-8390-0930

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.

Publications

Additive Role of Plasma von Willebrand Factor Levels to Clinical Factors for Risk Stratification of Patients With Atrial Fibrillation

Selecting Patients With Atrial Fibrillation for Anticoagulation

Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation

Frequent Co-Authors

Gregory Y.H. Lip

Deirdre A. Lane

Robert G. Hart

Brian F. Gage

Lesly A. Pearce

Peter J. Koudstaal

Researcher Info

External Links

Identifiers

Impact Metrics